References


  1. Data on file, Amylin Pharmaceuticals, Inc. and Eli Lilly and Company.
  2. Del Prato S, Pulizzi N. The place of sulfonylureas in the therapy for type 2 diabetes mellitus. Metabolism. 2006;55(suppl 1):S20-S27.
  3. IMS Health data. March 2007.